Business
Why the Incannex Healthcare (ASX:IHL) share price is up 15% today
The Incannex Healthcare Limited (ASX: IHL) share price has hit a 5-year high at 29 cents during early trade. The shares have since retreated back to 26 cents, up 18%.
All the excitement comes after the company released an announcement this morning pertaining to an ongoing research program.
Positive results prompting further research
Incannex Healthcare is a pharmaceutical development company utilising medicinal cannabis and psychedelics to generate treatments for a range of disorders and diseases. In today’s update, Incannex discussed the positive results of using its proprietary anti-inflammatory IHL-675A in treating inflammatory bowel disease (IBD).
The company’s IHL-675A treatment is a combination of cannabidiol ‘CBD’…
-
Noosa News19 hours agoMeet Chad Burgess, Pauline Hanson’s One Nation Party
-
General24 hours agoNew Zealand wants more ‘automated decision-making’ in its welfare system. Could that lead to Robodebt 2.0?
-
Noosa News22 hours agoFrom Dreamy Dining Rooms to Moody Basement Bars, Nearly 200 Venues Have Been Shortlisted for the 2025 Australian Interior Design Awards
-
Noosa News19 hours agoWestern Queensland graziers begin grim stock count after catastrophic floods